Corbus Pharmaceuticals Holdings Inc. Stock Slides 7.7%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slid 7.7% to $4.41 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.9% to 26,692.87 and Dow Jones Industrial Average falling 0.1% to 51,621.48.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 78.6% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 1.9% to $4.22, Fortress Biotech Inc. fell 2.6% to $1.90, and Viking Therapeutics Inc. fell 4.43% to $25.47.

Trading volume totaled 1.3 million, compared to the 50-day average of 933,647.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 14, 2026 16:33 ET (20:33 GMT)